Long term exposure to γ‑rays induces radioresistance and enhances the migration ability of bladder cancer cells

Mao,Guangmin; Yao,Ye; Kong,Zhaolu

doi:10.3892/mmr.2018.9605

Long term exposure to γ‑rays induces radioresistance and enhances the migration ability of bladder cancer cells

Authors:
- Guangmin Mao
- Ye Yao
- Zhaolu Kong
View Affiliations

Affiliations: Department of Radiobiology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, P.R. China, Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China
Published online on: October 26, 2018 https://doi.org/10.3892/mmr.2018.9605
Pages: 5834-5840

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In Western countries, bladder cancer (BCa) is one of the most common types of malignancy, with highest incidence rate among urinary system malignancies. At present, as a strategy to preserve the quality and function of the bladder tissues, external‑beam radiotherapy has been applied to an increasing number of patients with BCa, particularly the elderly and those in poor health. The onset of acquired radioresistance (ARR) during radiotherapy notably reduces the effectiveness of radiotherapy; however, the cause of ARR is unclear and remains untreatable. In order to investigate the mechanism of ARR, clinical fractionated irradiation was mimicked in vitro to obtain radioresistant BCa cells, 5637R, in the present study. Compared with the parental cell line, 5637R cells exhibited an increased distribution of S phase cells, enhanced migration ability and elevated levels of phosphorylated‑STAT3, as determined using flow cytometry, cell migration analysis and western blotting, respectively. Furthermore, 5637R cells exhibited notable increases in extracellular signal‑regulated kinase activation in response to ionizing radiation (IR) compared with 5637 cells. In addition, 5637R cells showed an early G2/M arrest within 8 h post‑IR (18.23±3.85 vs. 6.42±3.82%, IR cells vs. control cells), whereas 5637 cells were arrested in G2/M phase 24 h post‑IR (19.26±2.21 vs. 12.36±4.45%, IR cells vs. control cells). Overall, the present study suggested that phosphorylated STAT3 may be a potential biomarker to predict radioresistance and tumor recurrence in patients with BCa following conventional radiotherapeutic intervention. In addition, co‑treatment with ERK inhibitor may be a viable approach to increase the anticancer efficacy of radiotherapy in patients with ARR; however, further investigation is required.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Miyake M, Morizawa Y, Hori S, Tatsumi Y, Onishi S, Owari T, Iida K, Onishi K, Gotoh D, Nakai Y, et al: Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Cancer Sci. 108:2221–2228. 2017. View Article : Google Scholar : PubMed/NCBI
3	Chang Y, Xu J and Zhang Q: Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer. Oncol Lett. 14:4043–4052. 2017. View Article : Google Scholar : PubMed/NCBI
4	Li X, Wang Y, Xu J and Zhang Q: Sandwich ELISA for detecting urinary Survivin in bladder cancer. Chin J Cancer Res. 25:375–381. 2013.PubMed/NCBI
5	Ogihara K, Kikuchi E, Yuge K, Ito Y, Tanaka N, Matsumoto K, Miyajima A, Asakura H and Oya M: Refraining from smoking for 15 years or more reduced the risk of tumor recurrence in non-muscle invasive bladder cancer patients. Ann Surg Oncol. 23:1752–1759. 2016. View Article : Google Scholar : PubMed/NCBI
6	Nam JK, Park SW, Lee SD and Chung MK: Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer. Yonsei Med J. 55:1214–1221. 2014. View Article : Google Scholar : PubMed/NCBI
7	Chou R, Selph SS, Buckley DI, Gustafson KS, Griffin JC, Grusing SE and Gore JL: Treatment of muscle-invasive bladder cancer: A systematic review. Cancer-Am Cancer Soc. 122:842–851. 2016.
8	Soloway MS: ICUD-EAU International consultation on bladder cancer 2012: Recommendations on bladder cancer-progress in a cancer that lacks the limelight. Eur Urol. 63:1–3. 2013. View Article : Google Scholar : PubMed/NCBI
9	Bloom HJ, Hendry WF, Wallace DM and Skeet RG: Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol. 54:136–151. 1982. View Article : Google Scholar : PubMed/NCBI
10	Chang R, He H, Mao G and Kong Z: Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells. Int J Radiat Biol. 93:386–393. 2017. View Article : Google Scholar : PubMed/NCBI
11	Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT and Saha D: Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res. 70:2829–2839. 2010. View Article : Google Scholar : PubMed/NCBI
12	He H, Chang R, Zhang T, Yang C and Kong Z: ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway. Mol Med Rep. 16:1216–1222. 2017. View Article : Google Scholar : PubMed/NCBI
13	Bhattacharya S, Ray RM and Johnson LR: STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J. 392:335–344. 2005. View Article : Google Scholar : PubMed/NCBI
14	Shimura T: Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res. 52:539–544. 2011. View Article : Google Scholar : PubMed/NCBI
15	Shimura T: Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy. Int J Radiat Biol. 93:381–385. 2017. View Article : Google Scholar : PubMed/NCBI
16	Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
17	Chen CL, Cen L, Kohout J, Hutzen B, Chan C, Hsieh FC, Loy A, Huang V, Cheng G and Lin J: Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer. 7:782008. View Article : Google Scholar : PubMed/NCBI
18	Yang C, Zhang W, Wang L, Kazobinka G, Han X, Li B and Hou T: Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway. Lab Invest. 96:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
19	Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007. View Article : Google Scholar : PubMed/NCBI
20	Cargnello M and Roux PP: Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
21	Roskoski R Jr: ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol Res. 66:105–143. 2012. View Article : Google Scholar : PubMed/NCBI
22	Sebolt-Leopold JS and Herrera R: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer. 4:937–947. 2004. View Article : Google Scholar : PubMed/NCBI
23	Chen RJ, Ho YS, Guo HR and Wang YJ: Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci. 115:118–130. 2010. View Article : Google Scholar : PubMed/NCBI
24	Li Y, Guo G, Song J, Cai Z, Yang J, Chen Z, Wang Y, Huang Y and Gao Q: B7-H3 promotes the migration and invasion of human bladder cancer cells via the PI3K/Akt/STAT3 signaling pathway. J Cancer. 8:816–824. 2017. View Article : Google Scholar : PubMed/NCBI